Contract Development And Manufacturing Organizations (CDMO)

Celonic: Soenke Brunswieck appointed as Vice President Cell & Gene Therapy

Addressing Challenges in Sterile Manufacturing

Lonza Adds More Building Blocks for the Healthcare Continuum

Bernard Pluta Appointed as President of Recipharm’s Development Services

Lynn Lewis Appointed as SVP of Global Sales at Envigo

Celonic Acquires Glycotope Bio-manufacturing Facility

Both Positive and Negative Effects

CMC Biologics Hikes Capacity in Denmark

Ensuring Better Efficiency and Consistency

Earning a Large Chunk of the Cake

Pharma R&D Productivity Needs Improvement

Confidentiality is a Potential Pitfall

Consolidation is here to Stay

Changes in Portfolios and Pipelines are Likely

Setting High Standards

A Partner to Relieve the Strain

M&A in Pharma and CRO/CMO Industry

Innovative Companies Have to Deal with Risks

The Expanding Role of Contract Manufacturing

Neuland Laboratories Opens Dedicated Process Engineering Lab

Vistin Pharma Sells Opioids/CMO business to TPI Enterprises

JSR Life Sciences Acquires Selexis

Lubrizol Hikes Drug Product Manufacturing Capacity

Thermo Fisher to Buy Patheon for $7.2 Billion

A Difficult Path Ahead

Ashland Buys Pharmachem Laboratories

Slovakia’s Saneca Gets Grant to Boost R&D

The Winning Formula

West Expands Contract Manufacturing in Ireland.

Trends in Chemical & Pharmaceutical Research

ISPE Recognizes Leaders in Drug Shortage Prevention

Opportunities in Drug Development and Manufacturing

Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active pharmaceutical ingredients (APIs) and finished drug products.

The Winning Formula

Bridging the Innovation Gap

Piramal Adds Ash Stevens for $53 Million